SAM
CVS icon

Stansberry Asset Management’s CVS Health CVS Stock Holding History

Stansberry Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,929
Closed -$750K – 128
2024
Q3 		$750K Sell
11,929
-161,004
-93% -$9.39M 0.09% 105
2024
Q2 		$10.2M Sell
172,933
-37,750
-18% -$2.36M 1.34% 24
2024
Q1 		$16.8M Sell
210,683
-21,812
-9% -$1.67M 2.27% 10
2023
Q4 		$18.4M Sell
232,495
-31,622
-12% -$2.25M 3.05% 5
2023
Q3 		$18.4M Buy
264,117
+6,580
+3% +$466K 3.23% 4
2023
Q2 		$17.8M Buy
257,537
+32,814
+15% +$2.33M 3.26% 7
2023
Q1 		$16.7M Sell
224,723
-11,783
-5% -$988K 3.24% 7
2022
Q4 		$22M Buy
236,506
+4,684
+2% +$452K 4.55% 2
2022
Q3 		$22.1M Buy
231,822
+16,349
+8% +$1.62M 4.78% 1
2022
Q2 		$20M Sell
215,473
-3,691
-2% -$360K 4.25% 2
2022
Q1 		$22.2M Buy
219,164
+10,747
+5% +$1.13M 3.6% 4
2021
Q4 		$21.5M Buy
208,417
+8,892
+4% +$822K 3.44% 6
2021
Q3 		$16.9M Buy
199,525
+63,156
+46% +$5.29M 3.4% 8
2021
Q2 		$11.4M Buy
136,369
+4,732
+4% +$388K 2.75% 13
2021
Q1 		$9.9M Buy
131,637
+1,301
+1% +$94.8K 2.62% 15
2020
Q4 		$8.9M Buy
130,336
+2,998
+2% +$195K 2.5% 14
2020
Q3 		$7.44M Sell
127,338
-88
-0.1% -$5.48K 2.54% 13
2020
Q2 		$8.28M Buy
127,426
+4,563
+4% +$287K 3.56% 10
2020
Q1 		$7.29M Buy
122,863
+81,406
+196% +$5.43M 3.83% 9
2019
Q4 		$3.08M Buy
41,457
+6,688
+19% +$470K 1.25% 29
2019
Q3 		$2.19M Buy
34,769
+2,695
+8% +$160K 0.97% 32
2019
Q2 		$1.75M Buy
+32,074
New +$1.73M 0.69% 36

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Stansberry Asset Management's CVS Position: Q4 2024 in Review

Stansberry Asset Management sold out of CVS Health (CVS) in Q4 2024, closing a stake of 11,929 shares — an estimated $750K sold.

Stansberry Asset Management first reported a position in CVS in Q2 2019 and held it in 22 quarters. The position peaked at $22.2M in Q1 2022. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Stansberry Asset Management reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Stansberry Asset Management sold 11,929 CVS Health shares in Q4 2024, an estimated $750K.
  • Stansberry Asset Management first reported a position in CVS Health in Q2 2019 and held it in 22 quarters.
  • Stansberry Asset Management's CVS Health position peaked at $22.2M in Q1 2022.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Stansberry Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.